The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease
Sign Up to like & getrecommendations! Published in 2024 at "Clinical Cardiology"
DOI: 10.1002/clc.24284
Abstract: The 2023 Multisociety Guideline for the Management of Chronic Coronary Disease (CCD) updates recommendations for CCD, formerly known as “stable ischemic heart disease.” This condition encompasses a spectrum of coronary vascular pathologies from subclinical to… read more here.
Keywords: disease; guideline management; coronary disease; chronic coronary ... See more keywords
LIGHT is increased in patients with coronary disease and regulates inflammatory response and lipid metabolism in oxLDL-induced THP-1 macrophages.
Sign Up to like & getrecommendations! Published in 2017 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2017.06.110
Abstract: Inflammation is critical for the progression of hyperlipidemia. Although the exact mechanism through which inflammation affects hyperlipidemia is not very clear, evidence suggests that the tumor necrosis factor superfamily member 14 (TNFSF14/LIGHT)LIGHT might regulate lipid… read more here.
Keywords: coronary disease; thp macrophages; induced thp; oxldl induced ... See more keywords
Trimetazidine in conditions other than coronary disease, old drug, new tricks?
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.02.083
Abstract: Trimetazidine (TMZ) has traditionally been used as an anti-ischemic drug for coronary artery disease by selectively inhibiting the mitochondrial long-chain 3-ketoacyl-CoA thiolase. Recently, new applications for this therapy have been investigated. This article reviews alternative… read more here.
Keywords: trimetazidine conditions; conditions coronary; disease; drug ... See more keywords
Predictive value of cerebral natriuretic peptide in acute myocardial infarction without obstructive coronary disease
Sign Up to like & getrecommendations! Published in 2023 at "European Heart Journal: Acute Cardiovascular Care"
DOI: 10.1093/ehjacc/zuad036.067
Abstract: Type of funding sources: None. The brain natriuretic peptide (BNP) has a protective role on the coronary vasculature. On the other hand, vascular dysfunction is one of the main factors associated with acute myocardial infarction… read more here.
Keywords: disease; obstructive coronary; myocardial infarction; coronary disease ... See more keywords
Changes in coronary disease management decisions in real-world practice between 2015 and 2023: insights from the EVAREST/BSE-NSTEP observational study
Sign Up to like & getrecommendations! Published in 2025 at "European Heart Journal Cardiovascular Imaging"
DOI: 10.1093/ehjci/jeaf099
Abstract: Abstract Aims To assess the real-world impact of updated clinical guidelines and literature on the management of patients undergoing stress echocardiography for the assessment of inducible ischaemia across a national health service. Methods and results… read more here.
Keywords: 2015 2023; coronary disease; real world; disease management ... See more keywords
Left main coronary disease: evolving management concepts.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac542
Abstract: Remarkable advances in the management of coronary artery disease have enhanced our approach to left main coronary artery (LMCA) disease. The traditional role of coronary artery bypass graft surgery has been challenged by the less… read more here.
Keywords: disease; main coronary; management; left main ... See more keywords
HDL-cholesterol, genetics, and coronary artery disease: the myth of the 'good cholesterol'?
Sign Up to like & getrecommendations! Published in 2018 at "European heart journal"
DOI: 10.1093/eurheartj/ehy299
Abstract: Coronary disease remains a leading cause of death and disability in developed countries, and development of more effective prevention and treatment strategies is of paramount importance. Lowering LDL-cholesterol by targeting HMG-CoA reductase (using statins), Niemann–Pick… read more here.
Keywords: hdl cholesterol; risk; disease; cholesterol ... See more keywords
Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study.
Sign Up to like & getrecommendations! Published in 2023 at "Chinese medical journal"
DOI: 10.1097/cm9.0000000000002723
Abstract: BACKGROUND Risk assessment and treatment stratification for three-vessel coronary disease (TVD) remain challenging. This study aimed to investigate the prognostic value of left atrial volume index (LAVI) with the Synergy Between Percutaneous Coronary Intervention with… read more here.
Keywords: vessel coronary; syntax; death; risk ... See more keywords
Quantification of Ischemia As a Prognostic Mandate for Coronary Revascularization in Asymptomatic Patients: How Much Is Enough?
Sign Up to like & getrecommendations! Published in 2019 at "Critical Pathways in Cardiology"
DOI: 10.1097/hpc.0000000000000176
Abstract: The aim of this study was to investigate whether asymptomatic patients with known coronary artery disease and demonstrable myocardial ischemia warrant revascularization on prognostic grounds. A Medline and PubMed search was performed, including 7 trials… read more here.
Keywords: asymptomatic patients; ischemia; coronary disease; revascularization ... See more keywords
SAT0352 Prevalence and characteristics of coronary disease and cardiovascular risk factors in a cohort of patients with psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.7146
Abstract: Background We performed a descriptive study of our patients with psoriatic arthritis (PsA) over 40 years old, attending to the presence of coronary disease and cardiovascular risk factors in each group of treatment (DMARDS vs… read more here.
Keywords: psoriatic arthritis; risk; risk factors; disease ... See more keywords
Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial
Sign Up to like & getrecommendations! Published in 2025 at "Heart"
DOI: 10.1136/heartjnl-2024-325527
Abstract: Background Low-dose colchicine (0.5 mg once daily) reduces the risk of major cardiovascular events in coronary disease, but its mechanism of action is not yet fully understood. We investigated whether low-dose colchicine is associated with changes… read more here.
Keywords: low dose; plaque; pericoronary inflammation; colchicine ... See more keywords